218 related articles for article (PubMed ID: 19409936)
1. Peripheral mechanisms in the control of appetite and related experimental therapies in obesity.
Camilleri M
Regul Pept; 2009 Aug; 156(1-3):24-7. PubMed ID: 19409936
[TBL] [Abstract][Full Text] [Related]
2. Intestinal GLP-1 and satiation: from man to rodents and back.
Steinert RE; Beglinger C; Langhans W
Int J Obes (Lond); 2016 Feb; 40(2):198-205. PubMed ID: 26315842
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal satiety signals in humans--physiologic roles for GLP-1 and PYY?
Beglinger C; Degen L
Physiol Behav; 2006 Nov; 89(4):460-4. PubMed ID: 16828127
[TBL] [Abstract][Full Text] [Related]
4. Gut hormones as peripheral anti obesity targets.
Small CJ; Bloom SR
Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
[TBL] [Abstract][Full Text] [Related]
5. Intestinal glucagon-like peptide-1 effects on food intake: Physiological relevance and emerging mechanisms.
Krieger JP
Peptides; 2020 Sep; 131():170342. PubMed ID: 32522585
[TBL] [Abstract][Full Text] [Related]
6. The role of the stomach in the control of appetite and the secretion of satiation peptides.
Steinert RE; Meyer-Gerspach AC; Beglinger C
Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E666-73. PubMed ID: 22215654
[TBL] [Abstract][Full Text] [Related]
7. The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.
Madsbad S
Diabetes Obes Metab; 2014 Jan; 16(1):9-21. PubMed ID: 23617798
[TBL] [Abstract][Full Text] [Related]
8. Mycoprotein reduces energy intake and postprandial insulin release without altering glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations in healthy overweight and obese adults: a randomised-controlled trial.
Bottin JH; Swann JR; Cropp E; Chambers ES; Ford HE; Ghatei MA; Frost GS
Br J Nutr; 2016 Jul; 116(2):360-74. PubMed ID: 27198187
[TBL] [Abstract][Full Text] [Related]
9. Gut hormones and appetite regulation.
Hong SH; Choi KM
Curr Opin Endocrinol Diabetes Obes; 2024 Jun; 31(3):115-121. PubMed ID: 38511400
[TBL] [Abstract][Full Text] [Related]
10. Whey Proteins Reduce Appetite, Stimulate Anorexigenic Gastrointestinal Peptides and Improve Glucometabolic Homeostasis in Young Obese Women.
Rigamonti AE; Leoncini R; Casnici C; Marelli O; Col A; Tamini S; Lucchetti E; Cicolini S; Abbruzzese L; Cella SG; Sartorio A
Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678029
[TBL] [Abstract][Full Text] [Related]
11. Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
Iepsen EW; Torekov SS; Holst JJ
Expert Opin Pharmacother; 2014 Dec; 15(17):2487-500. PubMed ID: 25260877
[TBL] [Abstract][Full Text] [Related]
12. New physiological effects of the incretin hormones GLP-1 and GIP.
Asmar M
Dan Med Bull; 2011 Feb; 58(2):B4248. PubMed ID: 21299928
[TBL] [Abstract][Full Text] [Related]
13. Appetite, Glycemia, and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant, and Duodenal Administration of a Mixed-Meal Test After Roux-en-Y Gastric Bypass.
Gero D; Steinert RE; Hosa H; Cummings DE; Bueter M
Diabetes Care; 2018 Jun; 41(6):1295-1298. PubMed ID: 29636353
[TBL] [Abstract][Full Text] [Related]
14. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
[TBL] [Abstract][Full Text] [Related]
15. Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism.
Perez-Tilve D; Nogueiras R; Mallo F; Benoit SC; Tschoep M
Endocrine; 2006 Feb; 29(1):61-71. PubMed ID: 16622293
[TBL] [Abstract][Full Text] [Related]
16. The satiety hormone peptide YY as a regulator of appetite.
Vincent RP; le Roux CW
J Clin Pathol; 2008 May; 61(5):548-52. PubMed ID: 18441153
[TBL] [Abstract][Full Text] [Related]
17. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
18. The Role of Glucagon-Like Peptide-1 in Energy Homeostasis.
Salehi M; Purnell JQ
Metab Syndr Relat Disord; 2019 May; 17(4):183-191. PubMed ID: 30720393
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine control of food intake.
Valassi E; Scacchi M; Cavagnini F
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
[TBL] [Abstract][Full Text] [Related]
20. The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review.
Frezza EE; Wachtel MS; Chiriva-Internati M
Dig Dis Sci; 2007 Mar; 52(3):643-9. PubMed ID: 17268838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
